Global Mrna Cancer Vaccines and Therapeutics Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS12436 | Category: Agriculture | Pages: 128 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3350.00 Multi User-$5700.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Mrna Cancer Vaccines and Therapeutics, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mrna Cancer Vaccines and Therapeutics.

The Mrna Cancer Vaccines and Therapeutics market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Mrna Cancer Vaccines and Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mrna Cancer Vaccines and Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Mrna Cancer Vaccines and Therapeutics market size in 2022 is 54990.0 million US dollars, and it is expected to be 165038.3 million US dollars by 2029, with a compound annual growth rate of 17.00% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Mrna Cancer Vaccines and Therapeutics market include Moderna Therapeutics (US), eTheRNA (Belgium), BioNTech (Germany), CureVac (Netherlands), and In-Cell-Art (France). The share of the top 3 players in the Mrna Cancer Vaccines and Therapeutics market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Mrna Cancer Vaccines and Therapeutics market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Adeno Carcinomas accounted for XX% of Mrna Cancer Vaccines and Therapeutics market in 2022. Mucinous Carcinomas share of XX%.
Hospitals & Clinics accounted for XX% of the Mrna Cancer Vaccines and Therapeutics market in 2022. Ambulatory Surgical Centers accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, and global Mrna Cancer Vaccines and Therapeutics market status and forecast by region.
Chapters 2-3: Segmented the global Mrna Cancer Vaccines and Therapeutics market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 4: Analysis of the competitive environment of Mrna Cancer Vaccines and Therapeutics market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Mrna Cancer Vaccines and Therapeutics market country segmentation data.
Chapter 10: Analyzes the main companies in the Mrna Cancer Vaccines and Therapeutics industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 12: The main points and conclusions of the report.
Chapter 13: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
Moderna Therapeutics (US)
eTheRNA (Belgium)
BioNTech (Germany)
CureVac (Netherlands)
In-Cell-Art (France)
Translate Bio (US)
Tiba Biotechnology (US)
Argos Therapeutics (US)
Sangamo Therapeutics (US)
and Ethris (Germany).

Types list
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas

Application list
Hospitals & Clinics
Ambulatory Surgical Centers
Research Institutes
Others

Table of Content

1 Mrna Cancer Vaccines and Therapeutics Market Overview
1.1 Mrna Cancer Vaccines and Therapeutics Product Overview
1.1.1 Mrna Cancer Vaccines and Therapeutics Product Scope
1.1.2 Mrna Cancer Vaccines and Therapeutics Market Status and Outlook
1.2 Global Mrna Cancer Vaccines and Therapeutics Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Mrna Cancer Vaccines and Therapeutics Market Size by Region (2018-2029)
1.4 Global Mrna Cancer Vaccines and Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Mrna Cancer Vaccines and Therapeutics Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Mrna Cancer Vaccines and Therapeutics Market Size (2018-2029)
1.6.1 North America Mrna Cancer Vaccines and Therapeutics Market Size (2018-2029)
1.6.2 Europe Mrna Cancer Vaccines and Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Mrna Cancer Vaccines and Therapeutics Market Size (2018-2029)
1.6.4 Latin America Mrna Cancer Vaccines and Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Mrna Cancer Vaccines and Therapeutics Market Size (2018-2029)
2 Mrna Cancer Vaccines and Therapeutics Market Overview by Type
2.3 Global Mrna Cancer Vaccines and Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Mrna Cancer Vaccines and Therapeutics Historic Market Size by Type (2018-2023)
2.5 Global Mrna Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Mrna Cancer Vaccines and Therapeutics Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Mrna Cancer Vaccines and Therapeutics Market Size Breakdown by Type
2.6.3 Asia-Pacific Mrna Cancer Vaccines and Therapeutics Market Size Breakdown by Type
2.6.4 Latin America Mrna Cancer Vaccines and Therapeutics Market Size Breakdown by Type
2.6.5 Middle East and Africa Mrna Cancer Vaccines and Therapeutics Market Size Breakdown by Type
3 Mrna Cancer Vaccines and Therapeutics Market Overview by Application
3.3 Global Mrna Cancer Vaccines and Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Mrna Cancer Vaccines and Therapeutics Historic Market Size by Application (2018-2023)
3.5 Global Mrna Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Mrna Cancer Vaccines and Therapeutics Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Mrna Cancer Vaccines and Therapeutics Market Size Breakdown by Application
3.6.3 Asia-Pacific Mrna Cancer Vaccines and Therapeutics Market Size Breakdown by Application
3.6.4 Latin America Mrna Cancer Vaccines and Therapeutics Market Size Breakdown by Application
3.6.5 Middle East and Africa Mrna Cancer Vaccines and Therapeutics Market Size Breakdown by Application
4 Mrna Cancer Vaccines and Therapeutics Competition Analysis by Players
4.1 Global Mrna Cancer Vaccines and Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mrna Cancer Vaccines and Therapeutics as of 2022)
4.3 Date of Key Players Enter into Mrna Cancer Vaccines and Therapeutics Market
4.4 Global Top Players Mrna Cancer Vaccines and Therapeutics Headquarters and Area Served
4.5 Key Players Mrna Cancer Vaccines and Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Mrna Cancer Vaccines and Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Mrna Cancer Vaccines and Therapeutics Market Segment by Country
5.1 North America Mrna Cancer Vaccines and Therapeutics Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Mrna Cancer Vaccines and Therapeutics Market Segment by Country
6.1 Europe Mrna Cancer Vaccines and Therapeutics Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Mrna Cancer Vaccines and Therapeutics Market Segment by Country
7.1 Asia-Pacific Mrna Cancer Vaccines and Therapeutics Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Mrna Cancer Vaccines and Therapeutics Market Segment by Country
8.1 Latin America Mrna Cancer Vaccines and Therapeutics Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Mrna Cancer Vaccines and Therapeutics Market Segment by Country
9.1 Middle East & Africa Mrna Cancer Vaccines and Therapeutics Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  Moderna Therapeutics (US)
10.1.1 Moderna Therapeutics (US) Information
10.1.2 Business Overview
10.1.3 Moderna Therapeutics (US) Mrna Cancer Vaccines and Therapeutics Revenue, Gross Margin
10.1.4 Mrna Cancer Vaccines and Therapeutics Products Offered
10.1.5 Moderna Therapeutics (US) Recent Development
10.2  eTheRNA (Belgium)
10.2.1 eTheRNA (Belgium) Information
10.2.2 Business Overview
10.2.3 eTheRNA (Belgium) Mrna Cancer Vaccines and Therapeutics Revenue, Gross Margin
10.2.4 Mrna Cancer Vaccines and Therapeutics Products Offered
10.2.5 eTheRNA (Belgium) Recent Development
10.3  BioNTech (Germany)
10.3.1 BioNTech (Germany) Information
10.3.2 Business Overview
10.3.3 BioNTech (Germany) Mrna Cancer Vaccines and Therapeutics Revenue, Gross Margin
10.3.4 Mrna Cancer Vaccines and Therapeutics Products Offered
10.3.5 BioNTech (Germany) Recent Development
10.4  CureVac (Netherlands)
10.4.1 CureVac (Netherlands) Information
10.4.2 Business Overview
10.4.3 CureVac (Netherlands) Mrna Cancer Vaccines and Therapeutics Revenue, Gross Margin
10.4.4 Mrna Cancer Vaccines and Therapeutics Products Offered
10.4.5 CureVac (Netherlands) Recent Development
10.5  In-Cell-Art (France)
10.5.1 In-Cell-Art (France) Information
10.5.2 Business Overview
10.5.3 In-Cell-Art (France) Mrna Cancer Vaccines and Therapeutics Revenue, Gross Margin
10.5.4 Mrna Cancer Vaccines and Therapeutics Products Offered
10.5.5 In-Cell-Art (France) Recent Development
10.6  Translate Bio (US)
10.6.1 Translate Bio (US) Information
10.6.2 Business Overview
10.6.3 Translate Bio (US) Mrna Cancer Vaccines and Therapeutics Revenue, Gross Margin
10.6.4 Mrna Cancer Vaccines and Therapeutics Products Offered
10.6.5 Translate Bio (US) Recent Development
10.7  Tiba Biotechnology (US)
10.7.1 Tiba Biotechnology (US) Information
10.7.2 Business Overview
10.7.3 Tiba Biotechnology (US) Mrna Cancer Vaccines and Therapeutics Revenue, Gross Margin
10.7.4 Mrna Cancer Vaccines and Therapeutics Products Offered
10.7.5 Tiba Biotechnology (US) Recent Development
10.8  Argos Therapeutics (US)
10.8.1 Argos Therapeutics (US) Information
10.8.2 Business Overview
10.8.3 Argos Therapeutics (US) Mrna Cancer Vaccines and Therapeutics Revenue, Gross Margin
10.8.4 Mrna Cancer Vaccines and Therapeutics Products Offered
10.8.5 Argos Therapeutics (US) Recent Development
10.9  Sangamo Therapeutics (US)
10.9.1 Sangamo Therapeutics (US) Information
10.9.2 Business Overview
10.9.3 Sangamo Therapeutics (US) Mrna Cancer Vaccines and Therapeutics Revenue, Gross Margin
10.9.4 Mrna Cancer Vaccines and Therapeutics Products Offered
10.9.5 Sangamo Therapeutics (US) Recent Development
10.10  and Ethris (Germany).
10.10.1 and Ethris (Germany). Information
10.10.2 Business Overview
10.10.3 and Ethris (Germany). Mrna Cancer Vaccines and Therapeutics Revenue, Gross Margin
10.10.4 Mrna Cancer Vaccines and Therapeutics Products Offered
10.10.5 and Ethris (Germany). Recent Development
11 Mrna Cancer Vaccines and Therapeutics Market Dynamics
11.1 Mrna Cancer Vaccines and Therapeutics Industry Trends
11.2 Mrna Cancer Vaccines and Therapeutics Growth Drivers
11.3 Mrna Cancer Vaccines and Therapeutics Market Challenges
11.4 Mrna Cancer Vaccines and Therapeutics Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Mrna Cancer Vaccines and Therapeutics Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?